These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36505799)

  • 1. PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration.
    Wang S; Wang H; Zhu S; Wang Z
    Front Oncol; 2022; 12():1058506. PubMed ID: 36505799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma.
    Wang S; Ma X; Ying Y; Sun J; Yang Z; Li J; Jin K; Wang X; Xie B; Zheng X; Liu B; Xie L
    Cancer Cell Int; 2021 Jul; 21(1):341. PubMed ID: 34217271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer.
    Wang S; Wang H; Zhu S; Li F
    Front Oncol; 2022; 12():1040892. PubMed ID: 36353567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma.
    Zhao H; Lu G
    Front Genet; 2022; 13():905581. PubMed ID: 35754829
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer.
    Sun X; Xin S; Jin L; Zhang Y; Ye L
    Bioengineered; 2022 May; 13(5):13986-13999. PubMed ID: 35758021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAC3 Promotes Proliferation, Migration and Invasion via PYCR1/JAK/STAT Signaling in Bladder Cancer.
    Cheng C; Song D; Wu Y; Liu B
    Front Mol Biosci; 2020; 7():218. PubMed ID: 33062641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression COL10A1 promotes breast cancer progression and predicts poor prognosis.
    Zhou W; Li Y; Gu D; Xu J; Wang R; Wang H; Liu C
    Heliyon; 2022 Oct; 8(10):e11083. PubMed ID: 36281404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF2 Impairs Nrf2 Signaling through the Akt/Mtor Pathway in the Development of Bladder Cancer.
    Yu X; Li S; Ke S; Ye C; Wang Q; Wang H; Wang L
    J Cancer; 2024; 15(11):3242-3253. PubMed ID: 38817867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer.
    Zhao K; Zhang Q; Zeng T; Zhang J; Song N; Wang Z
    Transl Androl Urol; 2021 Mar; 10(3):1229-1240. PubMed ID: 33850758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
    Feng F; Chen AP; Wang XL; Wu GL
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5310-5319. PubMed ID: 32495864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXA10 promotes the development of bladder cancer through regulating FOSL1.
    Cui YP; Xie M; Pan WX; Zhang ZY; Li WF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2945-2954. PubMed ID: 32271412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ISYNA1 is overexpressed in bladder carcinoma and regulates cell proliferation and apoptosis.
    Guo X; Li HH; Hu J; Duan YX; Ren WG; Guo Q; Liu PH; Cui Y; Liu LF; Chen MF; Chen JB; Zu XB
    Biochem Biophys Res Commun; 2019 Nov; 519(2):246-252. PubMed ID: 31495492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
    Wang FH; Ma XJ; Xu D; Luo J
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
    Zhu L; Cui K; Weng L; Yu P; Du Y; Zhang T; Liu H; Li B; Ma W
    PLoS One; 2021; 16(6):e0249174. PubMed ID: 34086679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway.
    He SZ; Wang Q
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of thymosin β10 correlates with disease progression and poor prognosis in bladder cancer.
    Wang B; Wang Z; Zhang T; Yang G
    Exp Ther Med; 2019 Nov; 18(5):3759-3766. PubMed ID: 31616507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ID2 Inhibits Bladder Cancer Progression and Metastasis
    Mao W; Wang K; Sun S; Wu J; Chen M; Geng J; Luo M
    Front Cell Dev Biol; 2021; 9():738364. PubMed ID: 34746132
    [No Abstract]   [Full Text] [Related]  

  • 19. A Novel HCC Prognosis Predictor EEF1E1 Is Related to Immune Infiltration and May Be Involved in EEF1E1/ATM/p53 Signaling.
    Han R; Feng P; Pang J; Zou D; Li X; Geng C; Li L; Min J; Shi J
    Front Oncol; 2021; 11():700972. PubMed ID: 34282404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCLK1 promotes malignant progression of breast cancer by regulating Wnt/β-Catenin signaling pathway.
    Wang YL; Li Y; Ma YG; Wu WY
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9489-9498. PubMed ID: 31773701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.